NCT04198766 2025-12-18Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Inhibrx Biosciences, IncPhase 1/2 Active not recruiting296 enrolled
NCT05704985 2025-05-29Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA BiosciencesPhase 1 Active not recruiting39 enrolled
NCT05358548 2024-04-10ATATcH Alternating Treatment Plans for Advanced CancerRutgers, The State University of New JerseyPhase 2 Recruiting150 enrolled
NCT00003569 2013-01-31Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and PaclitaxelRoswell Park Cancer InstituteCompleted2 enrolled
NCT00667641 2011-05-10Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsRutgers, The State University of New JerseyPhase 1 Completed16 enrolled